- The sensitive detection of circulating tumour cells in patients with differentiated thyroid cancer may precede the detection of relapse by other diagnostic studies – such as serum thyroglobulin – and thus may have important therapeutic and prognostic implications. We performed reverse transcription-polymerase chain reaction (RT-PCR) on blood samples from patients diagnosed with thyroid disease using two different RT-PCR sensitivities. Additionally, tissue specificity of TG mRNA-expression was determined using RNA extracts from 27 different human tissues. The lower limit of detection was 50–100 TG mRNA producing cells/ml blood using a ‘normal’ RT-PCR sensitivity and 10–20 cells/ml blood using a ‘high’ sensitivity. With the normal sensitivity TG mRNA was detected in 9/13 patients with thyroid cancer and metastasis, 63/137 patients with a history of thyroid cancer and no metastasis, 21/85 with non-malignant thyroid disease and 9/50 controls. With the high sensitivity TG mRNA was detected in 11/13 patients with thyroid cancer and metastasis, 111/137 patients with a history of thyroid cancer and no metastasis, 61/85 with non-malignant thyroid disease and 41/50 controls. Interestingly, using the normal RT-PCR sensitivity TG mRNA transcripts are specific for thyroid tissue and detectable in the peripheral blood of controls and patients with thyroid disease, which correlates with a diagnosis of metastasized thyroid cancer. However, with a high RT-PCR sensitivity, TG mRNA expression was found not to be specific for thyroid tissue and was not correlated with a diagnosis of thyroid cancer in patients. As a consequence, to date TG mRNA detected by RT-PCR in the peripheral blood cannot be recommended as a tumour marker superior to TG serum-level.
MetadatenVerfasserangaben: | Jörg BojungaGND, Sandra Johanna Röddiger, Michael Stanisch, Klaus Kusterer, Ralf Kurek, Heiner Renneberg, Stefan Adams, Elmar Lindhorst, Klaus-Henning UsadelGND, Petra-Maria Schumm-DraegerGND |
---|
URN: | urn:nbn:de:hebis:30:3-457632 |
---|
DOI: | https://doi.org/10.1054/bjoc.1999.1209 |
---|
ISSN: | 1532-1827 |
---|
ISSN: | 0007-0920 |
---|
Pubmed-Id: | https://pubmed.ncbi.nlm.nih.gov/10817499 |
---|
Titel des übergeordneten Werkes (Englisch): | British journal of cancer |
---|
Verlag: | Churchill Livingstone |
---|
Verlagsort: | Edinburgh |
---|
Dokumentart: | Wissenschaftlicher Artikel |
---|
Sprache: | Englisch |
---|
Jahr der Fertigstellung: | 2000 |
---|
Datum der Erstveröffentlichung: | 21.04.2000 |
---|
Veröffentlichende Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Datum der Freischaltung: | 05.03.2018 |
---|
Freies Schlagwort / Tag: | molecular diagnostics; polymerase chain reaction; reverse transcription; thyroglobulin mRNA; thyroid cancer |
---|
Jahrgang: | 82 |
---|
Ausgabe / Heft: | 10 |
---|
Seitenzahl: | 6 |
---|
Erste Seite: | 1650 |
---|
Letzte Seite: | 1655 |
---|
Bemerkung: | From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
---|
HeBIS-PPN: | 431861773 |
---|
Institute: | Medizin / Medizin |
---|
DDC-Klassifikation: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Lizenz (Deutsch): | Creative Commons - Namensnennung-Keine kommerzielle Nutzung-Weitergabe unter gleichen Bedingungen |
---|